 |
 |
Dr. Reddy's to release Q3 FY12 results on February 3, 2012
Earnings call slated for February 3, 6.30 PM IST / 8.00 AM EST
Hyderabad, India, January 16, 2012: Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third Quarter ended and Nine Months ended December 31, 2011 on Friday February 3, 2012 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com
Summary of Events
| Event | Date and Time (IST) | Medium |
Release of financial results |
February 3, after the Board Meeting |
Email, Media, Company website, Businesswire |
Earnings Call |
February 3, 6.30 PM IST / 8:00 AM EST |
Hosted by the Company |
Webcast of Earnings Call |
February 3, 6.30 PM IST / 8:00 AM EST through February 8, 2012 |
URL available on Company’s website, www.drreddys.com |
Transcripts of the Earnings call |
Will be available on the Company’s website |
URL available on Company’s website, www.drreddys.com |
Earnings Call
Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.
| Conference Dial-In Numbers | |
Primary Number: |
+91 22 6629 0356 |
Secondary Number: |
+91 22 3065 0136 |
| The numbers listed above are universally accessible from all networks and all countries. | |
| Local Access Number: | 6000 1221 |
| International Toll Free Number: | USA: 1 866 746 2133 |
No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.
Audio Webcast
The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through February 8, 2012. For play back dial in phone No: 022 3065 1212 and ID: 375#.
Transcript
The transcript of the earnings call will also be available on the Company's website.
About Dr Reddy’s
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs. Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and pediatrics. Major markets include India, USA, Russia and CIS, Germany, UK, Venezuela, S. Africa, Romania, and New Zealand. For more information, log on to: www.drreddys.com
Contact
For further information please contact:
Investor Relations:
Kedar Upadhye at kedaru@drreddys.com /+91 40 66834297
Raghavender R at raghavenderr@drreddys.com /+91 40 49002135
Milan Kalawadia (USA) at mkalawadia@drreddys.com / +1 9082034931
